Cell surface markers in multiple myelomaRUIZ-ARGÜELLES, G. J; SAN MIGUEL, J. F.Mayo Clinic proceedings. 1994, Vol 69, Num 7, pp 684-690, issn 0025-6196Article

Prognostic factors and classification in multiple myelomaSAN MIGUEL, J. F; SANCHEZ, J; GONZALEZ, M et al.British journal of cancer. 1989, Vol 59, Num 1, pp 113-118, issn 0007-0920Article

Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphomaSAN MIGUEL, J. F; GARCIA-SANZ, R.Medical oncology (Northwood). 1998, Vol 15, pp S29-S34, issn 1357-0560, SUP1Article

T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and waldenstrom macroglobulinemiaSAN MIGUEL, J. F; CABARELLERO, M. D; GONZALEZ, M et al.American journal of hematology. 1985, Vol 20, Num 3, pp 267-273, issn 0361-8609Article

Immunophenotype and DNA cell content in multiple myelomaSAN MIGUEL, J. F; GARCIA-SANZ, R; GONZALEZ, M et al.Baillière's clinical haematology. 1995, Vol 8, Num 4, pp 735-759, issn 0950-3536Article

Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosisRAMIREZ, J. M; OCIO, E. M; SAN MIGUEL, J. F et al.Leukemia. 2007, Vol 21, Num 4, pp 797-804, issn 0887-6924, 8 p.Article

Do myelomatous plasma cells really express surface immunoglobulins ?OCQUETEAU, M; SAN MIGUEL, J. F; GONZALEZ, M et al.Haematologica (Roma). 1996, Vol 81, Num 5, pp 460-463, issn 0390-6078Article

Expression of the FMC7 antigen in cases of B-lymphoproliferative diseasesORFAO, A; GONZALEZ, M; SAN MIGUEL, J. F et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 9, pp 1417-1418, issn 0277-5379Article

Method for the simultaneous labelling of terminal deoxynucleotidyl transferase (TdT) and membrane antigens = Méthode de marquage simultané de la désoxynucléotidyl transférase terminale et des antigènes membranairesTAVARES DE CASTRO, J; SAN MIGUEL, J. F; SOLER, J et al.Journal of clinical pathology. 1984, Vol 37, Num 6, pp 628-632, issn 0021-9746Article

«Coexpression of T and B surface markers in B-lymphoproliferative disorders with M-serum component»CABALLERO, M. D; GONZALEZ, M; SAN MIGUEL, J. F et al.Journal of clinical & laboratory immunology. 1985, Vol 18, Num 1, pp 53-54, issn 0141-2760Article

Myelodysplatic syndrome evolving to a mixed myeloid-lymphoid leukaemiaSAN MIGUEL, J. F; GONZALEZ, M; DEL CANIZO, M. C et al.Hematological oncology. 1986, Vol 4, Num 2, pp 175-176, issn 0278-0232Article

Immunological phenotype of neoplasms involving the B cell in the last step of differentiationSAN MIGUEL, J. F; CABALLERO, M. D; GONZALEZ, M et al.British journal of haematology. 1986, Vol 62, Num 1, pp 75-83, issn 0007-1048Article

Alterations in tumor necrosis factor-α, interferon-γ, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism : Relationship with liver disease and ethanol intakeLASO, F.-J; LAPENA, P; MADRUGA, J. I et al.Alcoholism, clinical and experimental research. 1997, Vol 21, Num 7, pp 1226-1231, issn 0145-6008Article

Combination fo interferon an dexamethasone in refractory multiple myelomaSAN MIGUEL, J. F; MORO, M; BLADEÊ, J et al.Hematological oncology. 1990, Vol 8, Num 4, pp 185-189, issn 0278-0232, 5 p.Article

Discrepancies between morphologic, cytochemical, and immunologic characteristics in acute myeloblastic leukemiaDEL CANIZO, M. C; SAN MIGUEL, J. F; GONZALEZ, M et al.American journal of clinical pathology. 1987, Vol 88, Num 1, pp 38-42, issn 0002-9173Article

Coexpression of T- and B-markers in a lymphoproliferative disorderSAN MIGUEL, J. F; FORONI, L; GONZALEZ, M et al.Scandinavian journal of haematology. 1986, Vol 37, Num 1, pp 10-17, issn 0036-553XArticle

Acute leukemia of hybrid phenotype: T lymphoid and myelomonocytic markersGONZALEZ, M; ALVAREZ DE MON, M; SAN MIGUEL, J. F et al.Clinical immunology and immunopathology (Print). 1985, Vol 35, Num 2, pp 139-145, issn 0090-1229Article

T cells subpopulations in untreated and treated patients with haemophilia A and BSAN MIGUEL, J. F; VICENTE, V; GONZALEZ, M et al.Blut. 1983, Vol 47, Num 5, pp 311-313, issn 0006-5242Article

Immune thrombocytopenic purpura secondary to endometriosisAMIGO, M. L; CABALLERO, M. D; VAZQUEZ, L et al.Haematologica (Roma). 1997, Vol 82, Num 5, pp 602-603, issn 0390-6078Article

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis : implications for minimal residual disease studieMACEDO, A; ORFAO, A; GONZALEZ, M et al.Leukemia. 1995, Vol 9, Num 6, pp 993-998, issn 0887-6924Article

Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. I: Ultrastructural morphology and cytochemistryPOLLI, N; ÓBRIEN, M; TAVARES DE CASTRO, J et al.British journal of haematology. 1985, Vol 59, Num 2, pp 277-296, issn 0007-1048Article

Changes in surface antigens of HL-60 cells during differentiation in vitroSAN MIGUEL, J. F; MCCARTHY, D. M; BERDJOUHI RODRIQUES et al.Blut. 1984, Vol 49, Num 5, pp 369-373, issn 0006-5242Article

The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repairMAISO, P; COLADO, E; OCIO, E. M et al.Leukemia. 2009, Vol 23, Num 12, pp 2265-2274, issn 0887-6924, 10 p.Article

In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesisCONSUELO DEL CANIZO, M; GALENDE, J; MOTA, A et al.Leukemia research. 1997, Vol 21, Num 7, pp 651-656, issn 0145-2126Article

Chronic prolymphocytoid leukaemia with an unusual immature immunophenotypeLIMA, M; COUTINHO, J; ORFAO, A et al.Journal of clinical pathology. 1994, Vol 47, Num 5, pp 461-463, issn 0021-9746Article